10.1016/j.neuroscience.2020.04.017 36 RajendramP.TorbicH.DuggalA.CampbellJ.HovdenM.DhawanV.et al (2021)
"So, it's not recommended to say people prescribed this medication can treat or prevent Alzheimer's disease." "But this study can help people who already have Type 2 diabetes or obesity and are high risk for Alzheimer's disease, it maybe can provide some evidence for medication selection," she added
This is why retatrutide dosing must be carefully managed, especially in people with insulin resistance or type 2 diabetes
Since many people cannot afford Wegovy given the demand, doctors have prescribed diabetes GLP-1 drugs for off-label use to promote weight loss in obese patients
This suggests it could help treat brain diseases like Alzheimer's and Parkinson's
Note that NVO is an ADR, so dividends are subject to Danish withholding tax at source